News

Stockhead on MSN4h
Health Check: Biotechs recover as peace descends on the FDA – for now
Global and US biotech shares have recovered from their lows on signs that the chaos created by the Trump administration is ...
Inquirer Business on MSN4h
FDA promises to cut by half approval time for new products
The country’s regulator on food, drugs and cosmetics is looking to speed up its approval process, targeting to cut by half ...
Preliminary Phase 1B/2 Data For REC-4881 In Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden
In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp burden at the Week ...
BusinessWorld on MSN18h
FDA expects speedier drug permit process
THE new Food and Drug Administration (FDA) application procedures are expected to reduce the drug permit process by as much ...
Immutep posts strong survival results for head and neck cancer patients
FDA meeting requested following Phase IIb trial showing median overall survival of 17.6 months without chemotherapy Immutep ...
Physician's Weekly1h
Has FDA’s Drug Development Tools Qualification Program Improved Drug Development?
Qualification program creates a pathway to evaluate Clinical Outcome Assessments (COAs) that capture a specific concept of interest (COI) in a specified Context of Use (COU). If successfully qualified ...